Good morning :)
Switch to
Place Order

Aarti Drugs Ltd

AARTIDRUGS
Health CarePharmaceuticals
SmallcapWith a market cap of ₹3,969 cr, stock is ranked 556
Low RiskStock is 1.78x as volatile as Nifty
428.650.23% (+1.00)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Investment Checklist
BasicPro
Go pro! Unlock deeper insights
Health CarePharmaceuticals
SmallcapWith a market cap of ₹3,969 cr, stock is ranked 556
Low RiskStock is 1.78x as volatile as Nifty

Key Metrics

PE RatioPE RatioPB RatioPB RatioDividend YieldDiv. Yield
19.363.830.23%
Sector PESector PESector PBSector PBSector Div YldSctr Div Yld
38.164.820.92%

Forecast & RatingsDetailed Forecast 

33%

Analysts have suggested that investors can buy this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Aarti Drugs Limited is a pharmaceutical company offering active pharmaceutical ingredients (APIs) in a range of therapeutic categories, such as anti-inflammatory, cardioprotectant, antifungals, antibiotic, antidiabetic, sedative and vitamins.

Investor PresentationView older 

Aug 4, 2022

PDF
View Older Presentations

Get more out of Tickertape, Go Pro!

Customise key metrics, see detailed forecasts, download stock data and more

Financial TrendFinancial statements 

2019202020212022+1.57+1.81+2.16+2.50+0.09+0.14+0.28+0.21
Revenue
Profit
All values in ₹ Thousand cr.
See financial statements

Holdings TrendDetailed holdings 

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

See detailed holdings

Recent EventsAll events 

General updates 
Announced OnAug 9, 2022

Aarti Drugs Limited has informed the Exchange about Intimation of approval of Reclassification of Promoter | Download

Aarti Drugs Limited has informed the Exchange about Intimation of approval of Reclassification of Promoter | Download

Annual General Meeting 
Announced OnAug 5, 2022

Aarti Drugs Limited has informed the Exchange about Voting results and Scrutinizer report of Annual General Meeting held on 04-Aug-2022 | Download

Aarti Drugs Limited has informed the Exchange about Voting results and Scrutinizer report of Annual General Meeting held on 04-Aug-2022 | Download

Cash Dividend 
Ex. DateFeb 9, 2022

Interim • Div/Share: ₹ 1

See all events